Related content

Heparin resistance in acute coronary syndromes

By Rich Jonathan   Maraganore John   Young Edward   Lidon Rosa-Maria   Adelman Burt   Bourdon Paul   Charenkavanich Supoat   Hirsh Jack   Theroux Pierre   Cannon Christopher  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 2, 2007-04 ,pp. : 93-100

Springer Publishing Company

Access to resources Recommend Favorite

Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes

By Al-Mallah Mouaz   Bazari Rasha   Jankowski Michelle   Hudson Michael  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 1, 2007-02 ,pp. : 51-55

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges

By van den Besselaar A.M.H.P.   Sturk A.   Reijnierse G.L.A.  

Thrombosis Research, Vol. 107, Iss. 5, 2002-09 ,pp. : 235-240

Elsevier

Access to resources Recommend Favorite

Antibodies to Platelet Factor 4/Heparin are Associated with Elevated Endothelial Cell Activation Markers in Patients with Acute Coronary Ischemic Syndromes

By Mascelli Mary   Deliargyris Efthymios   Damaraju Lakshmi   Barnathan Elliot   Califf Robert   Simoons Maarten   Sane David  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 171-175

Springer Publishing Company

Access to resources Recommend Favorite

Acute Coronary Syndromes in Patients with Chronic Kidney Disease

By  

Current Vascular Pharmacology, Vol. 11, Iss. 5, 2013-09 ,pp. : 758-767

Bentham Science Publishers

Access to resources Recommend Favorite